ACP6 Blocking Peptide (N-Term)
€363.00
In stock
SKU
AC-BP22045a
Background:
Hydrolyzes lysophosphatidic acid (LPA) containing a medium length fatty acid chain to the corresponding monoacylglycerol. Has highest activity with lysophosphatidic acid containing myristate (C14:0), monounsaturated oleate (C18:1) or palmitate (C16:0), and lower activity with C18:0 and C6:0 lysophosphatidic acid.
Other Names:
Lysophosphatidic acid phosphatase type 6, 3.1.3.2, Acid phosphatase 6, lysophosphatidic, Acid phosphatase-like protein 1, PACPL1, ACP6, ACPL1, LPAP
Target/Specificity:
The synthetic peptide sequence is selected from aa 136-146 of HUMAN ACP6
Gene Name: ACP6
Gene ID: 51205
Primary Accession: Q9NPH0
Other Accession: A6H757;Q5R8C0
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Hydrolyzes lysophosphatidic acid (LPA) containing a medium length fatty acid chain to the corresponding monoacylglycerol. Has highest activity with lysophosphatidic acid containing myristate (C14:0), monounsaturated oleate (C18:1) or palmitate (C16:0), and lower activity with C18:0 and C6:0 lysophosphatidic acid.
Other Names:
Lysophosphatidic acid phosphatase type 6, 3.1.3.2, Acid phosphatase 6, lysophosphatidic, Acid phosphatase-like protein 1, PACPL1, ACP6, ACPL1, LPAP
Target/Specificity:
The synthetic peptide sequence is selected from aa 136-146 of HUMAN ACP6
Gene Name: ACP6
Gene ID: 51205
Primary Accession: Q9NPH0
Other Accession: A6H757;Q5R8C0
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review